Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In the fourth quarter of 2024, we entered into a master services agreement with IQVIA ("IQVIA Master Services Agreement") to leverage IQVIA's infrastructure and established commercialization solutions to complement our AVMAPKI FAKZYNJA CO-PACK launch strategy.”
FILING10-K0001104659-26-023444cik 0001526119
“Cash used in investing activities for the 2025 Period primarily represents milestone payments recorded as intangible assets in the amounts of $7.5 million under the Pfizer Agreement and $2.1 million under the License Agreement.”
FILING10-K0001104659-26-023444cik 0001526119
“On January 7, 2020, we entered into a license agreement with Chugai (the "Chugai Agreement") whereby Chugai granted us an exclusive worldwide license for the development, commercialization, and manufacture of products containing avutometinib.”
FILING10-K0001104659-26-023444cik 0001526119
“In January 2025, we entered into a supply agreement with GenFleet pursuant to which GenFleet agreed to provide us with compound and licensed product for development use for VS-7375.”
FILING10-K0001104659-26-023444cik 0001526119
“Pursuant to the Secura APA, we sold to Secura our exclusive worldwide license for the research, development, commercialization, and manufacture in oncology indications of products containing duvelisib.”
FILING10-K0001104659-26-023444cik 0001526119
“The increase was also attributable to a $6.0 million payment made to exercise the GenFleet Option with respect to VS-7375.”
FILING10-K0001104659-26-023444cik 0001526119
Watchlist prices, news filtered to it, and its next report on your desk.
Verastem, Inc. has 5 disclosed suppliers and 1 disclosed customer. Each one is named in an SEC filing, either Verastem, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Verastem, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 7.33 · gapped below the open, then crossed back over prior close. High/low 7.47 at 11:30 am ET, 7.26 at 10:30 am ET.
VSTM (Verastem, Inc.) has 5 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: IQV +1.51%, in healthcare.